OVERVIEW

Value - Based Healthcare in Head and Neck Cancer is organized by The University of Texas MD Anderson Cancer Center and would be held during Nov 3 - 4, 2016 at The University of Texas MD Anderson Cancer Center, Robert C. Hickey Auditorium, Houston, Texas, United States Of America. The targeted audience for this medical event is basically for clinicians caring for head and neck cancer patients. This CME conference has been approved with 13.50 AMA PRA Category 1 Credits.

Objectives :

After participating in the activity, the participant should be able to
• Apply the principles of measuring value of healthcare and its importance in recent federal legislation to improve the value of individual practices. (Knowledge, Competence, Performance)
• Evaluate possible process changes in individual practices to identify, implement, and measure quality improvements such as payment incentives. (Knowledge, Competence, Performance)
• Demonstrate an understanding of quality improvement initiatives on institutional, national, and specialty-specific levels. (Knowledge, Competence, Performance)
• Apply insight and improvement techniques to participate in the development and implementation of standardized national quality measures based on best practice. (Knowledge, Competence)
• Demonstrate an understanding of the importance of patient perspective in the value of healthcare and apply methods of soliciting and implementing patient input in clinical practice. (Knowledge, Competence, Performance, Patient Outcomes)

KEY DATES

Event Start Date
03 Nov, 2016
Event Start Date
Event End Date
04 Nov, 2016
Event End Date

SPECIALITIES

Oncology

SUGGESTED HOTELS

CONFERENCE VENUE

LocationRobert C. Hickey Auditorium
UT MD Anderson Cancer Center,, Clark Clinic, R11.1100, 11th Floor 1515 Holcombe Blvd

RELATED CONFERENCES & LIVE WEBINARS

Feb 01 - 02, 2027 | Dubai, Dubai, UAE

Oncology
30 CME
...
More actions
GB£19

Feb 01 - 02, 2027 | Dubai, Dubai, UAE

Pathology
30 CME
...
More actions
GB£45

Oct 29 - 30, 2026 | Orlando, Florida, USA

Oncology
More actions
US$235